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Vitamin status 
- vitamin B 1 ? B 2 , 
and B 6 in erythrocytes 
- vitamin C, B 1 2 , A, E, 
and D, ß-carotene, folic acid 
and biotin in plasma 
Epileptics 
Vitamin Status in Patients 
on Chronic Anticonvulsant Therapy * 
K . - H . K R A U S E 1 , P . B E R L I T 1 , J . - P . B O N J O U R 2 , H . S C H M I D T - G A Y K 3 , 
B . S C H E L L E N B E R G 4 and J . G I L L E N 1 
Summary: Vitamin levels in blood were estimated in 146 epileptics, aged 
20-40 years. Compared to healthy subjects, no higher risk rates of a vitamin 
deficiency were found in epileptics for vitamins BUB12, A, C, Ε and ß-carotene. 
aEGR was elevated only in epileptic females, αΕοοτ in epileptic males, indicating 
a higher risk of a vitamin B> and B() deficiency in these groups. Markedly re­
duced levels of folate, 25-hydroxy-cholecalciferol, and biotin were found in the 
epileptics; folate and, biotin levels showed a significant negative correlation with 
the toted amount and the average daily dose of anticonvidsants administered. 
Introduction 
The influence of a long-term treatment with anticonvulsants on the metab­
olism of some vitamins (folate, vitamin D) is known; for others, i. e. vitamin B,; 
and vitamin E , such an effect is assumed, whereas for all other vitamins none 
was found or has not yet been investigated. The aim of this study was then to 
evaluate the vitamin status in epileptics on chronic anticonvulsant therapy and 
to compare their vitamin status with the results in healthy subjects. 
* Parts of this paper have been presented as a poster on the Epilepsy International Congress, 
Kyoto, September 17-21, 1981. 
1 Department of Epileptology and Clinical Neurophysiology, Neurological Clinic, University 
of Heidelberg, F. R. G. 
2 Department of Vitamin and Nutrition Research, F. Hoffmann-La Roche & Co., Basle, Switzer­
land. 
3 Department of Surgery, University of Heidelberg, F. R. G. 
4 Clinic of Internal Medicine, University of Heidelberg, F. R. G. 
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Patients and Methods 
145 patients (96 males, 49 females) aged 20-40 years attending the Heidelberg out-patient 
clinic for epileptics were investigated. Most patients were treated with a combination of the 
following anticonvulsants for at least one year: phenytoin (n = 60), primidone (n = 55), carba-
mazepine (n = 42), valproate sodium (n = 33), phenobarbital (n=14), ethosuximide (n=13). 
CHP-phenobarbital (barbexaclon) (n=12), clonazepam, mesuximide, mephenytoin, sulthiam 
and trimethadione. The total amount and the mean daily dose administered was calculated 
using equivalent units 5. 
The results of the vitamin estimation in patients with epilepsy were compared to the results 
of the "Heidelberg Study" [1] in which the vitamin status of 20-40 years old healthy subjects 
in the region of Heidelberg had been evaluated. Only where no corresponding vitamin levels 
were determined in the "Heidelberg Study" the Swiss "Jura Study" [26] was used for corn-
par." son. 
The supply situation of vitamin B x was evaluated measuring the erythrocyte transketolase 
activity (ETK) with (ETK + ) and without (ETK 0 ) added thiamin pyrophosphate under stand­
ardised condition. The technique is a modification of the methods of SCHOUTEN et al. [40] and 
DREYFUSS [11]. <*ETK (ETK + /ETK 0 ) is a measure of the vitamin BA status. Values of > 
1.25 correspond to the high risk category of a vitamin deficiency, values of α £ χ Κ < 1.15 to the 
low risk category; the intermediate range is marginal [5]. To assess the vitamin B 2 status the 
erythrocyte glutathione reductase (EGR) activity was determined according to GLATZLE et al. 
[14] without (EGR 0) added flavine adenine dinucleotide (FAD) and again after incubation 
with FAD (EGR + ). Values of a E G R > 1.29 belong to the high risk category, a E G R < 1.20 to the 
low risk category [5]. The status of vitamin B c was measured using the erythrocyte glutamate 
oxalacetate transaminase activation test (EGOT) as proposed by WEBER and WEGMAN [43] in 
which the apotransaminase is activated by pyridoxal-5'-phosphate. For higher workloads an 
automated version of the test according to TRINDER and KIRKLAND [42] was used. Subjects 
showing values of «EGOT ^ 1.80 with this test belong to the low risk category; subjects with 
a E G 0 T > 2.0 to the high risk category [5]. Biotin concentration in plasma was determined 
microbiologically using the technique of FRIGG and BRUBACHER [13]. Plasma biotin levels 
> 1.02nmol/l are usually determined with this method [3]. Vitamin C was assayed fluoro-
metrically [10] following the procedure described by BRUBACHER and VUILLEUMIER [7]. Plasma 
levels of vitamin C < 23 μιηοΐ/ΐ are considered to reflect inadequate supply [5]. The retinol-
binding protein (RBP) was measured by radial immunodiffusion [23]. RBP-values of 2.4-4.8 
μιτιοΐ/ΐ seem to be normal. The molar ratio of retinol over RBP, which normally lays between 
0.7 and 0.9, helps according to SMITH and GOODMAN [41] to identify cases of hypo- and hyper-
vitaminosis A. In the "Heidelberg Study" and "Jura Study" vitamin A was analysed in plasma 
by fluorometry after chromatographic separation [6]. The procedure has been combined with 
the assay of ß-carotene. Vitamin Ε was assayed by the colorimetric method proposed by H A S H I M 
and SCHUTTRINGER [17]. In the study with epileptics the plasma concentrations of vitamin A, E , 
and ß-carotene were determined by HPLC on an absorption mode silica column. Since a com-
parative study has shown no significant difference between the results of the two methods 
[J. P. VUILLEUMIER, personal communication] the values for the vitamins A, E, and ß-carotene 
can be compared between the "Heidelberg Study" and the "Epileptic Study". The vitamin A 
level is somewhat higher in males than in females. Assay values < 1.05 μπιοΐ/ΐ (100 IU/100 ml) 
may be considered to reflect a marginal supply situation [5]. No threshold values for vitamin Ε 
can be given. In industrialized countries plasma levels around 23.2 μιτιοΐ/ΐ and higher are found; 
values below 9.3 iimol/l are likely to reflect low supply [5]. The values for ß-carotene depend 
5 1 equivalent unit = 50mg phenytoin, 30 mg phenobarbital, 125 mg primidone, 50 mg CHP-
phenobarbital, 200 mg carbamazepine, 50 mg mephenytoin, 250 mg ethosuximide, 300 mg val-
proate sodium, 2 mg clonazepam, 300 mg mesuximide, 100 mg sulthiam, or 250 mg trimetha-
dione. 
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on diet and can only be used for the overall assessment of the nutritional status; no threshold 
values are known. 
Vitamin B 1 2 and folate were assayed by a simultaneous radioassay according to GUTCHO and 
MANSBACH [15 ] with minor modifications. Release of bound vitamins from their endogenous 
binders and the destruction of these binders are effected by a heating step at pH 9.3. The 
subsequent binding reactions with hog intrinsic factor and milk binder protein proceed simul­
taneously in the same tube at pH 9.3. Complete separation of bound radioactivities, 57Co-cyano-
cobalamin and 1 2 5I-labeled pteroylmonoglutamic acid-histamide is obtained in a dual channel 
gamma counter. Vitamin B 1 2 values < 150 pmol/1 and folate values < 3 nmol/1 seem to reflect 
a low supply [ 1 ] . 25-Hydroxycholecalciferol was determined by a radioassay in a modification 
of the method described by BELSEY et al. [ 2 ] . 25-Hydroxycholecalciferol standards were pre­
pared in vitamin D-deficient, charcoal treated serum instead of ethanol as described by the 
authors. The normal range is 50 to 3 0 0 nmol/1 with marked seasonal variation. 
Vitamin B 1 2 , folate, and 25-hydroxy-cholecalciferol determinations have been carried out at 
the Department of Surgery. University of Heidelberg, the others by F. Hoffmann-La Roche 
& Co., Basle. 
Results 
The mean values of the vitamin determinations and their distributions are 
given in table I and figures 1-6, respectively, both for male and female epileptic 
patients and their controls of the same age. The distributions are compiled only 
30 
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Fig. J: Distribution of VLyyyx-values in epileptics and normal population. 
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Tab. I : Vitamin status in epileptics and controls 
K p i l e p t i c s C o n t r o l s 
m a l e 1 f e m a l e m a l e 1 f e m a l e 
B t ( α Ε Τ Κ ) 1.10 ± 0.06 1.11 ± 0.06 1.12 ± 0.07 1.13 ± 0.09 
(n = 95) (n = 47) (n = 636) (n =744) 
B 2 ( a E G R ) 1.12 ± 0.11 1.16 ± 0.23 1.11 ± 0.11 1.00 ± 0.07 
(n = 96) (n = 49) (n = 633) (n = 749) 
B 6 ( a E G 0 T ) 1.86 ± 0.23 1.80 ± 0.26 1.76 ± 0.20 1.81 ± 0.26 
(n = 96) (n = 49) (n = 629) (n = 748) 
B 1 S (pmol/1) 335 ± 112 347 ± 123 570 ± 332 400 ± 264 
(n = 96) (n = 49) (n = 727) (n = 712) 
Biotin nmol/1 0.92 ± 0.34 0.88 ± 0.22 1.81 ± 0.732 1.88 ± 0.952 
(n = 75) (n = 42) (n = 57) (n = 36) 
Folate (nmol/1) 4.4 ± 3.1 5.0 ± 3.2 16.0 ± 16.0 7.0 ± 8.0 
(n = 94) (n = 49) (n = 624) (n = 714) 
C (μιηοΙ/1) 35.8 ± 16.5 43.8 ± 22.7 33.5 ±2S.9l 28.4 ±21.0 
(n = 96) (n = 49) (n = 488) (n = 355) 
ß-Carotene (μτηοΐ/ΐ) 0.61 ± 0.39 0.79 ± 0.76 0.59 ± 0.293 0.65 i 0.35 
(n = 95) (n = 49) (n = 75) (n = 582) 
A (μιτιοΐ/l) 2.27 ± 0.51 1.84 ± 0.52 2.78 ± 0.641 1.74 ± 0.45 
(n = 96) (n = 49) (n = 487) (n = 582) 
Retinol binding protein μπιοΐ/ΐ 3.04 ± 0.76 2.57 ± 0.67 3.14 ± 0.57:l 2.95 ± 0.57:t 
(n = 96) (n = 49) (n = 75) (n = 25) 
A/RBP (molar ratio) 0.75 ± 0.12 0.72 ± 0.05 0.74 ± 0.05:} 0.73 ± 0.04:l 
(n = 96) (n = 49) (n = 75) (n = 25) 
D (nmol/1) 103 ± 106 90 ± 74 140 ± 1 1 0 163 ± 71 
(n = 95) (n = 49) (n = 728) (n = 690) 
Ε (μιποί/) 24.8 ± 6.9 24.4 ± 4.4 29.2 ± 9.01 22.3 ± 4.4 
(n = 95) (n = 49) (n = 486) (n = 632) 
1 ]ura-study [26]. 
2 Blood donors and patients with dermatological disease [3]. 
:< Blood donors (Η. E. KELLER and J. P. VUILLEUMIER, personal communication). 
for those vitamins for which the values for both sexes were available from the 
"Heidelberg Study". The percentage of patients and controls falling into the 
high risk category of a vitamin deficiency can be found in table I I . 
When the correlation between vitamin levels and either the total amount or 
the daily dose of anticonvulsants administered was investigated by linear re­
gression a negative correlation (p < 0.05) was found for folate (figure 7) and 
biotin [20]. 
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«250 300 400 500 > 550 Β12 
(pmol/l) 
Fig. 4: Distribution of plasma levels of vitamin B 1 2 in epileptics and normal population. 
Tab. II: Percentage of epileptics and controls with a high risk of a vitamin deficiency 
V j l y m i n s 
E p i l e p t i c s C o n t r o l s 
m a l e J l e m a l c m a l e J f e m a l e 
B i « E T K t e 1-25) 2 4 6 7 
B s a K T K ( ^ 1.29) 4 15 7 0.1 
Β β α Ε Ο Ο τ ( £ 2 . 0 ) 24 18 11 18 
Β,., ( > 150 pmol/l) 1 2 3 9 
Biotin (1.02 nmol/1) 83 •81 9 2 0 2 
Folate ( < 3 nmol/1) 46 37 5 27 
C ( < 11.4umoI/l) 6 8 131 10 
A ( < 1.05 μmol/l) 0 2 0 9 
D ( < 50 nmol/1) 43 35 15 1 
Ε ( < 9.3 umol/1) 0 0 O1 0 
1 Jura-study [26]. 
2 Blood donors and patients with dermatological diseases [3]. 
25-OH-D(nmol/l) 
Fig. 6: Distribution oi plasma levels of 25-OH-cholecalciferol in epileptics and normal 
population. 
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FOLATE 
(nmol/l) 
18 
correlation coeff ic ient= -0.20(p<0.05) 
• · ··· · 
10 11 12 13 Η 15 16 17 18 
average daily intake (equivalent units/d) 
Fig. 7: Correlation between average daily intake of anticonvulsants (equivalent units/d) and 
plasma folate level. 
Discussion 
Slightly higher mean values were found for vitamin A, E , and C and for 
ß-carotene in the female epileptics than in the females of the "Heidelberg 
Study" [1]. In male patients slightly lower mean values for vitamins A and Ε 
and higher ones for vitamin C were noted than in male controls. The mean con­
trol values used for comparison were taken from the "Jura Study" [26], as in 
the "Heidelberg Study" these vitamins had not been determined for males. No 
increased risk of vitamin A, Ε and C deficiency was found in male and female 
epileptic patients. RBP and the ratio vitamin A / R B P were within normal limits 
for most epileptics. Therefore, a chronic anticonvulsant therapy does not seem 
to influence the status of vitamins A, E , and C ; these findings do not confirm the 
observations made by O K U N M E G A [28] and H I G A S H I el al. [18] who reported 
reduced vitamin Ε levels in epileptic children treated with anticonvulsants. 
The activation coefficient (ακτκ) for vitamin B t tended to be lower in male 
and female epileptic patients than in controls indicating a good vitamin Bi 
status in epileptics; also the risk of a vitamin Bi deficiency was higher in con­
trols. A higher mean (ij.;(;R and a substantially higher risk of a vitamin BL> defi­
ciency was noted in the female patients with epilepsy, whereas in males no such 
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differences were seen. The reason for this sex-specific distinction has not yet 
been elucidated; but should this be confirmed in a larger number of patients, 
investigations into a possible correlation wi th the hormonal condition of the 
female epileptics seem to be worthwhile . 
Impairment of the vi tamin B C ) status in patients treated wi th anticonvulsants 
has been reported [9, 30, 33]. Our investigations, using the E G O T activation 
test, noted a deterioration in the vi tamin B, 5 status for male patients only; both 
the mean values and the percentage wi th abnormal levels were higher than in 
controls. For females no such difference was found. This might be because 
female epileptics less often use oral contraceptives than do their healthy con­
trols. These agents are known to lower the vi tamin BG status [29]. Furthermore, 
some controversy exists about the usefulness of the E G O T activation test as an 
indicator of the vi tamin B ( 5 status. Not only are various methods used to measure 
activities [36] but in some cases the results may be misleading. For instance, in 
alcoholic subjects known to have an inadequate intake of vi tamin B G often a low 
<XEGOT> indicating no risk of a v i tamin B ß deficiency, is found [ 4 ] ; a similar phe-
nomenon might occur in anticonvulsant therapy. Therefore, a determination of 
the level of pyridoxal-5'-phosphate in erythrocytes as an additional parameter 
related to the vitamin B ( 5 status seems to be useful in further studies of the vita-
min B Ö status in epileptics. 
Mean circulating vi tamin Bi2 levels were reduced in patients suffering from 
epilepsy more so in males than in females, but the percentage of patients wi th 
a deficient level was lower than in the control population. Also other studies 
usually found no reduction of v i tamin B 1 2 levels in epileptics [9, 33, 38] and, 
therefore, a chronic treatment w i t h anticonvulsants should not lead to a more 
frequent occurrence of vi tamin B 1 2 deficiency symptoms in these patients than 
in the general population. 
Major differences in the v i tamin status of epileptics and controls were only 
found for folate, vitamin D and biotin. A reduction of folate levels on anti-
convulsant therapy has been known for some time [24], This reduction in folate 
levels is being discussed as a factor in the mode of action and as a cause for 
side-effects of anticonvulsants such as psychosis and haematological abnormal-
ities [31,32]. About 4 0 % of the epileptics investigated by us were found to have 
deficient folate levels, a figure which fits wel l into the published frequencies of 
2 9 % to 91 % [33]. Some investigations have found a correlation between folate 
levels and the doses of anticonvulsants administered [32, 34] whereas others 
have not [19]. Our results seem to indicate a certain dose-dependency (fig. 7). 
but the number of patients investigated, especially of those on monotherapy, 
are as yet too small to draw any definite conclusions. 
A n impaired vitamin D status is considered to be the cause of the anticon-
vulsant osteomalacia which has been described for the first time by K R U S E [22] 
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and SCHMID [37] in 1967/68. Deficient 25-hydroxy-cholecalciferol levels have 
been reported to occur in 23-39% of the epileptics investigated [16. 21, 25, 35]. 
A frequency of 3 5 % for the female and of 4 3 % for the male patients (table I I ) 
seems to be quite high. However, most of our patients have been investigated 
dur ing winter and spring, when 25-hydroxy-cholecalciferol levels are known 
to be low [39]. This seasonal variation might also be the reason why no correla­
t ion between plasma 25-hydroxy-cholecalciferol levels and the total amount or 
the mean daily dose of anticonvulsants administered has been found. Also the 
connection between 25-hydroxy-cholecalciferol levels and the skeletal mineral­
isation is not clear: in manifest osteopathy low 25-hydroxy-cholecalciferol lev­
els are generally noted [12, 21, 25], but in a number of patients treated wi th 
anticonvulsants low levels are seen without concurrent radiological signs of 
osteopathy. A retrospective study has shown that slight skeletal changes as 
demonstrated by radiology occur frequently in the first few years of anticon­
vulsant therapy. These changes tend to revert to normal in the majority of 
patients in the next few years; only in a few patients, mostly those treated wi th 
high doses for a long period, does a severe osteopathy develop [25]. Similarly, 
25-hydroxy-cholecalciferol levels might also decline during the first years of 
treatment wi th a subsequent normalization in most patients and a further de­
crease in only a few. This possibility w i l l be investigated in a larger number of 
patients. Furthermore, bone density measurements which are more sensitive 
than the conventional radiology [8] , should be used to assess the diagnostic 
value of 25-hydroxy-cholecalciferol levels. 
3-Methyl-
glutaconyl-CoA*-
3-Methyl-
-crotonyl-CoA 
Acetyl-CoA Methvl-malo-
nyl-CoA 
Acetyl-CoA- V'QI 7 PropiortYl-CoAz. 
carboxylase j 'carboxylase! 
Malonyl-CoA Propionyl-CoA 
-Mf*Oxalacetate Pyruvate -
= block in biotin deficiency 
Fig. 8: Increased carbon dioxide as hypothetical contribution of reduced biotin levels to the 
mode of action of anticonvulsants. 
The reduction of biotin levels in 8 0 % of the epileptics has been discussed 
elsewhere [20]. This reduction might be a factor in the efficacy of anticon­
vulsants: a decrease in the activity of the biotin-dependent carboxylase could 
lead to an increase in carbon dioxide (figure 8), and via the decrease of the 
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pyruvate carboxylase activity to a reduction of aspartate in brain (figure 9). 
Both these possibilities have to be considered as antiepileptic mechanisms of 
action. The pharmacological effect of a biotin deficiency in epileptics deserves 
further attention. 
Pyruvate 
Pyruvatecarb-
oxylase 1 
OxalacetateJ 
Aspartate I 
Fig. 9: Decreased aspartate as hypothetical contribution of reduced biotin levels to the mode 
of action of anticonvulsants. 
Acknowledgment: We thank Dr. J. P. Vuilleumier, Department of Vitamin and Nutrition 
Research, F. Hoffmann-La Roche, Basle, and his co-workers for carrying out most of the vita­
min determinations and F. Biekert, Institut für Medizinische Dokumentation und Statistik der 
Universität Heidelberg, for the statistical analyses. 
This work was supported by grant Kr 659/1 from the Deutsche Forschungsgemeinschaft. 
References 
1. ARAB, L. . SCHELLENBERG, B., SCHLIKRF, G.: Beiträge zu Infusionen und klinischer Ernäh-
rung, Band 7. Karger, Basel, München, Paris. London, New York, Sydney, 1981. - 2. BKLSEY, R. 
E., DELUCA, H . F., POTTS jr., J. T . : J . clin. Endoer. 38, 1046 (1974). - 3. BONJOUR, J. P.: Internat. 
J. Vit. Nutr. Res. 47, 107 (1977). - 4. BONJOUR, j . P.: Internat. J. Vit . Nutr. Res. .«>ö, 2 1 5 (1980). -
5. BRUBACHER, G.: Zur Ernährungssituation der schweizerischen Bevölkerung, Brubacher, G.. 
Ritzel. G., ed., Hans Huber, Bern, Stuttgart, Wien, 1975, p. 27. - 6. BRUBACHER, G.. V U I L L E U -
MIER, J. P.: Clinical Biochemistry, Principles and Methods, Curtius, H . C., Roth, M., ed., W. de 
Gruytcr. Berlin. New York. 1974. p. 9 7 5 . - 7 . BRUBACHER. G.f VUILJ.KUMJO, J. P.; Clinical Biochem-
istry Principles and Methods, Curtius, H . C. Roth, M., ed., W. de Gruyter, Berlin, New York. 
1974, p. 989. - 8. CHRISTIANSEN, C, RODBRO, P., DREWSEN, B.: Acta med. Scand. 200, 293 (1976). 
- 9. DAVIS, R. E., REED, P. Α., SMITH, Β. K.: Epilepsia 16, 463 (1975). - 10. DEUTSCH, Μ. J., WEEKS, 
C.E.: J. of the Λ.Ο. A.C. 48, 1248 (1965). - 11. DRKYFUSS, P .M. : New Engl. J. Med. 267. 596 
(1962). - 12. FLURY, W.: Schweiz, med. Wschr. 102, 1333 ( 1 9 7 2 ) . - 13.FRIGG, M. , BRUBACHER, G.: 
Internat. J .Vi t . Nutr. Res. 46, 3 1 4 (1976). - 14. GLATZLE, D., KÖRNER, W. F., CHRISTELLER, S., 
WISS, 0 . : Internat. J. Vit. Nutr. Res 40, 166 (1970). - 15. GUTCHO, S., MANSBACH, L . : Clin. chem. 
23. 1609 (1977). - 16 H A H N , Τ . J., HENDIN, Β. Α., SCHARP, C. R., HADDAD, J. G.: New Engl. J. 
Med. 287, 900 (1972). - 17. HASHIM, S.A., SCHUTTRINGER, G. R.: Amer. J. Clin. Nutr. 19, 137 
(1966). - 18. HIGASHI , Α., T A M A R I , H. , IKEDA, Τ . , OHTANI , Y., MATSUKURA, M. , MIYOSHINO. S., 
MATSUDA, I . : Pediatric Pharmacology 1, 129 (1980). - 19. KORCZYN, A . D . , E U A N , M. , DON, R.. 
BORNSTEIN, Β.: J. Neurol. 207, 151 (1974). - 20. KRAUSE, K.-H. , BEREIT, P., BONJOUR, J. P.: Arch. 
Psychiat. Nervenkr. 231, 141 (1982). - 2 1 . KRAUSE, K.-H. , PRAGER, P., SCHMIDT-GAYK. H. , RITZ. 
Ε.: Dtsch. med. Wschr. 102, 1872 (1977). - 22. KRUSE, R.: Mschr. Kinderheilk. 116, 378 (1968). -
23. M A N C I N I , G., CARBONARA, A. 0 . , HEREMANS, J.F.: Immunochemistry 2, 235 (1965). - 24. 
MANNHEIMER, Ε., PAKESCH. F., REIMER. Ε. Ε.. VETTER, Η . : Med. Klin. 47, 1397 (1952). - 25. 
Κ . - Η . KRAUSE et al.: Vitamin Status and Anticonvulsant Therapy 385 
MEHREGAN, U., KRAUSE, K . - H . , PRAGER. P.: Arch. Psychiat. Ncrvenkr. 226, 299 (1979). -
26. MOESCHLER, P.: Arch. Suisses d'Anthropologie generale 35, 1 (1971). - 27. MOSEKILDE, 
L.. MELSEN, F., CHRISTENSEN, Μ. S., LUND, Β., SORENSEN, Ο. H. : Acta med. Scand. 201. 
303 (1977). - 28. OGUNMEKAN, A. 0 . : Epilepsia 20, 295 (1979). - 29. REINKEN, L . , DAPUNT, 
O., KAMMERLANDER, Η.: Internat. J . Vit. Nutr. Res 43, 20 (1973). - 30. REINKEN, L . , HOHE­
NAUER, L . , ZIEGEER, Ε. E.: Clin. chim. Acta 36, 270 (1972). - 3 1 . REYNOLDS, E . H . : Brain 
91, 197 (1968). - 32. REYNOLDS, E . H . : Antiepileptic Drugs, Woodbury, D. M. , Penry, J. 
K . . Schmidt, R. P., ed., Raven Press, New York, 1972, p. 247. - 33. REYNOLDS, Ε. H. : Epi­
lepsia 16, 3 1 9 (1975). - 34. REYNOLDS, Ε. H . , MATTSON, R. H . , GALLAGHER, Β . B.: Neurology 
(Minneap.) 22, 841 (1972). - 35. RIBOT, C, GERAUD, G., CASTIGNOL, M . el al.: Ann. Endocr. 
(Paris) 37. 483 (1976). - 36. SÄUBERLICH, Η. E., CANHAM, J. E., BAKER, Ε. M. , RAICA, N. , HER­
MAN, Y. F.: Amer. J. Clin. Nutr. 25, 629 (1972). - 37. SCHMID, F.: Fortschr. Med. 85, 381 (1967). 
- 38. SCHMIDT, D.: Behandlung der Epilepsien. Thieme, Stuttgart, New York, 1981. - 39. 
SCHMIDT-GAYK, H . , MARTISKAINEN, I . , STENGEL, R., HAUEISEN, Η.: Vitamin D and Problems to 
Uremic Bone Disease, W. de Gruyter, Berlin, New York, 1975, p. 339. - 40. SCHOUTEN, H . , VAN 
EPS, L . W., BOUDIER, A. M.S.: Clin. chim. Acta 10, 474 (1964). - 4 1 . SMITH, F. R., GOODMAN, 
W. S.: J. Clin. Invest. 50. 2436 (1971). - 42. TRINDER, P., KIRLAND, J . F.: Technicon Symposia 
"'Automation in analytical chemistry" 1965, Skeggs, L . T., ed., Mediad Inc., New York, 1966. 
p. 609. - 43. WEBER, H . , WEGMANN, T.: Atlas der klinischen Enzymologie, appendix methods, 
Thieme, Stuttgart. 1968, p. 8. 
Dr. K.-H. Krause, Neurological Clinic, University of Heidelberg, 
Voss-Str. 2, D - 6900 Heidelberg L F. R. G. 
